tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ENGN Stock Latest News

3 ‘Strong Buy’ Stocks to Buy Today,12/24/2025, According to Top Analysts
Market News3 ‘Strong Buy’ Stocks to Buy Today,12/24/2025, According to Top Analysts
2h ago
NOW
ENGN
Reaffirming Buy on enGene: Strengthened LEGEND Phase 2 Data, Robust Cash Runway to 2028, and Path to 2026 BLA for Detalimogene
PremiumRatings
Reaffirming Buy on enGene: Strengthened LEGEND Phase 2 Data, Robust Cash Runway to 2028, and Path to 2026 BLA for Detalimogene
3h ago
ENGN
enGene (ENGN): Advancing Detalimogene Toward Commercialization in NMIBC with Practical Competitive Edge Justifies Buy Rating and $25 Target
PremiumRatings
enGene (ENGN): Advancing Detalimogene Toward Commercialization in NMIBC with Practical Competitive Edge Justifies Buy Rating and $25 Target
1d ago
ENGN
enGene: Strong LEGEND Data, Regulatory Tailwinds, and Solid Cash Runway Support Buy Rating and $19 Target
PremiumRatings
enGene: Strong LEGEND Data, Regulatory Tailwinds, and Solid Cash Runway Support Buy Rating and $19 Target
1d ago
ENGN
enGene reports FY25 EPS $2.29 vs. $1.46 last year
PremiumThe Fly
enGene reports FY25 EPS $2.29 vs. $1.46 last year
2d ago
ENGN
Strong Buy Rating for enGene Driven by Regulatory Advancements and Market Readiness of Detalimogene
PremiumRatingsStrong Buy Rating for enGene Driven by Regulatory Advancements and Market Readiness of Detalimogene
22d ago
ENGN
enGene’s Detalimogene Chosen for FDA Manufacturing Pilot Program
Premium
Company Announcements
enGene’s Detalimogene Chosen for FDA Manufacturing Pilot Program
22d ago
ENGN
enGene detalimogene voraplasmid selected for FDA manufacturing pilot program
Premium
The Fly
enGene detalimogene voraplasmid selected for FDA manufacturing pilot program
22d ago
ENGN
enGene to Present at Piper Sandler Healthcare Conference
PremiumCompany Announcements
enGene to Present at Piper Sandler Healthcare Conference
29d ago
ENGN
enGene Holdings Closes $130 Million Public Offering
PremiumCompany Announcements
enGene Holdings Closes $130 Million Public Offering
1M ago
8K
ENGN
enGene 12.559M share Spot Secondary priced at $8.50
PremiumThe Fly
enGene 12.559M share Spot Secondary priced at $8.50
1M ago
ENGN
enGene Holdings Prices $130 Million Public Offering to Advance Genetic Medicine Programs
PremiumCompany Announcements
enGene Holdings Prices $130 Million Public Offering to Advance Genetic Medicine Programs
1M ago
ENGN
enGene Holdings Announces Public Offering of Common Shares
PremiumCompany AnnouncementsenGene Holdings Announces Public Offering of Common Shares
1M ago
ENGN
enGene announves common shares offering, no amount given
Premium
The Fly
enGene announves common shares offering, no amount given
1M ago
ENGN
enGene price target raised to $19 from $18 at Morgan Stanley
Premium
The Fly
enGene price target raised to $19 from $18 at Morgan Stanley
1M ago
ENGN
enGene price target raised to $33 from $30 at Oppenheimer
PremiumThe Fly
enGene price target raised to $33 from $30 at Oppenheimer
1M ago
ENGN
enGene price target raised to $10 from $4 at UBS
PremiumThe Fly
enGene price target raised to $10 from $4 at UBS
1M ago
JNJ
CGON
Cautious Hold Rating for enGene Holdings Amid Competitive Trial Results and Market Uncertainty
PremiumRatings
Cautious Hold Rating for enGene Holdings Amid Competitive Trial Results and Market Uncertainty
1M ago
ENGN
enGene price target raised to $21 from $18 at Citizens JMP
PremiumThe Fly
enGene price target raised to $21 from $18 at Citizens JMP
1M ago
ENGN
Here’s Why enGene Holdings Stock Is Soaring Today
PremiumMarket NewsHere’s Why enGene Holdings Stock Is Soaring Today
1M ago
ENGN
Midday Fly By: SoftBank exits Nvidia, CoreWeave cuts guidance
Premium
The Fly
Midday Fly By: SoftBank exits Nvidia, CoreWeave cuts guidance
1M ago
V
BP
Promising Advancements in enGene Holdings’ Clinical Trials Justify Buy Rating
Premium
Ratings
Promising Advancements in enGene Holdings’ Clinical Trials Justify Buy Rating
1M ago
ENGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >